Year: 2018
Type: review
Abstract: With striking similarity to their adaptive T helper cell counterparts, innate lymphoid cells (ILCs) represent an emerging family of cell types that express signature transcription factors, including T-bet+ Eomes+ natural killer (NK) cells, T-bet+ Eomes– group 1 ILCs (ILC1), GATA3+ group 2 ILCs (ILC2), RORγt+ group 3 ILCs (ILC3), and newly identified Id3+ regulatory ILC (ILCreg). ILCs are abundantly present in barrier tissues of the host (e.g., the lung, gut, and skin) at the interface of host-environment interactions. Active research has been conducted to elucidate molecular mechanisms underlying the development and function of ILCs. The aryl hydrocarbon receptor (Ahr) is a ligand-dependent transcription factor, best known to mediate the effects of xenobiotic environmental toxins and endogenous microbial and dietary metabolites. Here we review recent progresses regarding Ahr function in innate lymphoid cells. We focus on the Ahr-mediated cross-talk between ILCs and other immune/non-immune cells in host tissues especially in the gut. We discuss the molecular mechanisms of the action of Ahr expression and activity in regulation of ILCs in immunity and inflammation, and the interaction between Ahr and other pathways/transcription factors in ILC development and function with their implication in disease.
Source: Frontiers in Immunology
Authors: Shiyang Li, John W. Bostick, Liang Zhou
Institutions: University of Florida, Northwestern University
Language: English
Topic: IL-33, ST2, and ILC Pathways
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W2782187941
